Biobank Diversity Facilitates Drug &amp; Diagnostic Development

Labant, MaryAnn

doi:10.1089/gen.32.2.21

Cited by 4 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Working with a network of collection sites and biobanks, they virtually source tissues to client specifications without actually collecting or storing samples and deliver them directly to the client. This streamlines the procurement of tissue and benefits all parties, as Labant notes, ‘The potential of fulfilling the request and the likelihood of being able to obtain rare samples is greater than going to a single biobank' [3]. Working in this way can be advantageous to both patients and scientists by facilitating wider access to samples.…”

Section: Biobank Growth and Trendsmentioning

confidence: 99%

“…Limited use of human tissues has in the past been attributed to limited numbers by lack of samples [2], and in particular reliable high-quality, annotated samples [2,3]. Human materials are now used at an early stage of drug discovery and pre-clinical testing in an attempt to address the high fail rate seen in the past 20 years which has resulted in the so-called ‘clinical cliff' [4,5].…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Biobanking Trends, Challenges, and Opportunities

Mackenzie¹

2014

Pathobiology

View full text Add to dashboard Cite

Objectives: To review the different interests and needs of industry and academic users of human biomaterials. Methods: A review of the current literature and interviews with involved parties. Questionnaires were e-mailed to assess current attitudes towards biobanking and opinions of trends and implications for the future. The organisations included commercial biobanks, charitable foundations, academic biobanks, and hospital sites. Results: Biobanks have the potential to have a critical impact across several industrial sectors, and their future success will depend on satisfying the differing needs of each group. There is a growing need for greater collaboration between researchers and biobanks, and if the involvement of industry is not sought by biobanks to create conditions that support the effective use of resources, there is a risk that samples will not be collected or used to the best advantage. Conclusions: It is evident that industry can play a vital role in the innovation process of biobanking, both in terms of the collecting and processing methods and the nature of the disease and sample types collected. With this feedback, biobanks can be utilised effectively to advance research to the benefits of all to the best advantage.

show abstract

Section: Biobank Growth and Trendsmentioning

confidence: 99%